What is the difference between Dealpath and Juniper Square?

Dealpath and Juniper Square solve different problems at opposite ends of the CRE lifecycle. Dealpath is a deal-side platform: it manages the acquisitions pipeline, deal scoring, diligence checklists, and document rooms from sourcing through close. Juniper Square is a capital-side platform: it manages the investor portal, capital calls, waterfall distributions, K-1 packages, and fund accounting from the raise through LP reporting. They are complementary, not competitive — Dealpath manages the asset you're buying, and Juniper Square manages the investors funding it.

Do I need both Dealpath and Juniper Square?

Many growing firms eventually run both, because they address different bottlenecks. If you're an acquisitions-led firm screening high deal volume, Dealpath solves the pipeline problem; if you're a fund GP with an institutional LP base, Juniper Square solves the investor-management problem. The right sequence is to anchor first on whichever pain is more acute today and add the second platform when the other side of the business starts to strain. They're commonly run side by side at institutional-grade firms — that's the norm, not a sign of overspending.

Which should a new GP buy first — Dealpath or Juniper Square?

It depends on your structure. A committed-fund GP raising from many LPs usually feels the capital-side pain first — late reporting, spreadsheet-run capital calls, an investor experience that looks amateur next to institutional peers — which argues for Juniper Square first. A high-volume acquisitions shop with capital already committed often feels the pipeline pain first, which argues for Dealpath. Below meaningful deal volume, an organized CRM can stand in for Dealpath for a while, whereas the LP-reporting burden rarely shrinks — so capital-side firms frequently anchor on Juniper Square first.

Can Dealpath handle investor reporting and capital calls?

No. Dealpath is built for the acquisitions side — pipeline, diligence, and deal management — and has no investor-facing portal, no capital-call mechanics, no distribution waterfalls, and no fund accounting. If you need to raise capital, run capital calls and distributions, issue K-1s, or give LPs a portal with capital-account statements, that's Juniper Square's job (or a peer like Agora or InvestNext), not Dealpath's.

Can Juniper Square manage my acquisitions pipeline?

No. Juniper Square is built for investor management, IR, and fund administration. It does not source, score, or diligence deals, and it has no acquisitions pipeline. For the deal-side workflow — pipeline stages, diligence checklists, document rooms, IC prep — you need a deal-management platform like Dealpath. The two are designed to sit on opposite ends of the firm's lifecycle.

How do you connect deal data in Dealpath to a capital raise in Juniper Square?

Out of the box, you don't — the link between them is manual. The underwritten numbers, deal thesis, and property facts that live in Dealpath have to be re-assembled by hand into the LP-facing materials and offering documents that go into Juniper Square. Both platforms are partner-gated for API access, and neither vendor builds the bridge between them. An automation layer closes that gap: a capital-raise copilot takes the approved deal data and drafts the investor memo, return narrative, and personalized LP outreach, so the deal carries across into the raise instead of being rebuilt from scratch.

Are Dealpath and Juniper Square open via API?

Both have real integration surfaces, but both are partner-gated rather than self-service. Dealpath integrates with ARGUS, DocuSign, and Box and exposes API access through its partner program. Juniper Square connects to fund accounting, banking and distribution rails, and CRM systems through partner-program API access. In practice, enrollment and lead time apply for either, so plan integration work into your timeline rather than assuming an instant connection.

Where does AI add the most value across the Dealpath-to-Juniper Square lifecycle?

At three points. First, deal intake: an AI deal-sourcing agent reads inbound offering memoranda, extracts the fields, scores against your criteria, and creates the Dealpath record automatically. Second, the deal-to-capital-raise bridge: a capital-raise copilot turns underwritten deal data into LP-ready memos, return narratives, and outreach for the offering in Juniper Square. Third, LP reporting: an LP-reporting agent drafts quarterly updates and distribution notices from the underlying fund data. The common thread is that AI feeds both platforms and connects the deal side to the capital side, so the same facts aren't keyed three times.

Dealpath vs Juniper Square: Acquisitions Pipeline vs Investor Management (2026)

"Dealpath vs Juniper Square" is a question we hear from GPs and sponsors trying to decide where to spend their first real software dollar — and like most either/or framings in CRE tech, it usually dissolves once you look at what each product actually does. Dealpath lives on the deal side: the acquisitions pipeline, diligence, and the path to close. Juniper Square lives on the capital side: the investor portal, capital calls, distributions, K-1s, and fund administration. They don't compete for the same job. They sit at opposite ends of the firm's lifecycle.

So the real buyer question isn't "which is better." It's "which pain is more acute right now, and which platform anchors the firm first." A two-person sponsor closing one or two deals a year but raising from 40 LPs has a capital-side problem before a pipeline problem. A high-volume acquisitions shop screening hundreds of deals on the strength of a committed fund has the opposite. This guide gives you the decision criteria, an objective head-to-head that names a winner per job, and the part most comparisons skip: where AI changes the answer by carrying deal data straight into the capital raise.

One note on positioning: NextAutomation is not a competitor to either platform. We're the AI/automation layer that populates and connects them — reading offering memoranda into the pipeline on one end, and turning underwritten deal data into LP-ready capital-raise narrative on the other. This piece is objective on Dealpath and Juniper Square first; the automation angle comes after the honest comparison.

Dealpath vs Juniper Square at a Glance

Dimension	Dealpath	Juniper Square
Primary job	Acquisitions deal pipeline & diligence management	Investor management, IR & fund administration
Lifecycle stage	Sourcing → underwriting → IC → diligence → close	Capital raise → subscriptions → distributions → LP reporting
Core user	Acquisitions analysts, investment teams, GPs	IR teams, fund accountants, GPs raising capital
Signature features	Configurable pipeline, diligence checklists, document rooms, deal scoring, task workflows	Investor portal, capital calls, waterfall distributions, K-1 packages, fund accounting
Who it's for	Buy-side firms running a structured, higher-volume acquisitions process	GPs and fund managers above the syndicator tier with an institutional LP base
Integrations	ARGUS, DocuSign, Box, email/calendar — partner-gated API	Fund accounting, banking/distributions, CRM — partner-gated API
Where it wins	When the bottleneck is finding, screening, and closing deals	When the bottleneck is raising, reporting to, and servicing LPs

The pattern in that table is the whole argument: these tools barely overlap. Dealpath manages the asset you're buying. Juniper Square manages the investors funding the purchase. The decision is less "which is better" and more "which side of the business is breaking first."

Buyer Decision Criteria

Before you can pick the platform that anchors your firm, you need to know which pain is more acute today. Score yourself against these:

Which side of the business is the constraint? If deals are slipping because nobody can see the pipeline, diligence falls through the cracks, or IC prep is a fire drill — that's a deal-side problem, and Dealpath is the answer. If LPs get reporting late, capital calls are run on spreadsheets, K-1 season is chaos, or your investor experience looks amateur next to institutional peers — that's a capital-side problem, and Juniper Square is the answer.
How are you structured — fund or deal-by-deal? A committed-fund GP with recurring LP obligations feels the IR/fund-admin pain constantly, which pulls toward Juniper Square first. A deal-by-deal sponsor syndicating each acquisition separately may feel pipeline pain first, especially if they're screening far more deals than they close.
How sophisticated is your LP base? Institutional LPs expect a professional portal, clean capital-account statements, and timely reporting; many have already used Juniper Square at other GPs. If you're raising from family offices and institutions, the investor experience is a fundraising asset, not just back-office hygiene — and that argues for anchoring on the capital side.
What's your deal volume and team size? Dealpath's value scales with pipeline volume and the number of people who need a shared source of truth on each deal. A shop screening hundreds of deals a year gets far more from it than one closing a handful. Below that volume, an organized CRM may hold you for a while; the LP-reporting burden, by contrast, rarely shrinks.
What does it need to talk to? Dealpath's ARGUS and DocuSign integrations matter for diligence-heavy buyers. Juniper Square's fund-accounting and banking/distribution connections matter for GPs who need investor activity to flow into the books. Both are partner-gated for API access — real integration surfaces, but enrollment and lead time apply.

Honest Head-to-Head: Who Wins, By Job

Because these platforms target different jobs, the only useful comparison is per job. Here's the objective call:

Managing an acquisitions pipeline & diligence → Dealpath wins

This is Dealpath's home turf and it's not close. Configurable deal stages, deal scoring, diligence checklists, document rooms, and task assignment give acquisitions teams a single source of truth from first look to close. Juniper Square has no acquisitions pipeline — it isn't designed to source, screen, or diligence deals. If your bottleneck is the buy-side workflow, Dealpath is the right answer, and Juniper Square doesn't compete.

Investor portal, capital calls & distributions → Juniper Square wins

Juniper Square is the category standard for GPs above the syndicator tier — investor portal, online subscriptions, capital calls, waterfall distributions, and capital-account statements that institutional LPs expect. Dealpath has no investor-facing portal and no fund mechanics. If your bottleneck is raising and servicing capital, Juniper Square wins outright.

LP reporting & K-1 / fund accounting → Juniper Square wins

Quarterly LP updates, capital-account reporting, K-1 packages, and fund-level accounting are core Juniper Square functions (with managed fund-admin services available). Dealpath isn't built for any of it. For the broader category, compare it against Agora and InvestNext in our best investor-portal software for real estate funds roundup.

Deal sourcing, screening & IC prep → Dealpath wins

Dealpath's pipeline, scoring, and diligence tooling are aimed squarely at the sourcing-to-IC gauntlet. This is the work that happens before a dollar of LP capital is committed, and Juniper Square plays no part in it.

Anchoring the whole firm on one platform → neither (and that's expected)

No single platform here covers deal-to-capital well, because they're solving genuinely different problems. Growing firms commonly run Dealpath on the deal side and Juniper Square on the capital side, with the link between them being the deal that becomes the offering you raise against. The friction is exactly that link — the underwritten numbers, the deal thesis, and the property facts that live in Dealpath have to be re-assembled by hand into the capital-raise materials and LP reporting that live in Juniper Square. That gap is where an automation layer earns its keep.

Where AI Changes the Answer

Both Dealpath and Juniper Square are systems of record — they're only as valuable as the data inside them, and at most firms that data is entered and re-entered by hand. The comparison shifts here, because the highest-leverage move isn't choosing between the two platforms. It's automating the bridge between them: turning a screened, underwritten deal into a capital raise without a manual re-build in the middle.

Deal intake that reads OMs into the pipeline

The single biggest drag on a Dealpath pipeline is manual data entry. An analyst gets a broker email with an offering memorandum attached, then re-keys the property name, address, asking price, NOI, and a dozen other fields into a new deal record. An AI deal-sourcing agent reads the inbound OM, extracts the structured fields, scores the deal against your acquisition criteria, and creates the pipeline record automatically — so the analyst starts at "is this worth pursuing," not "let me retype the OM."

Bridging the deal into the capital raise

This is the part neither vendor builds for you, and it's where the real time goes. Once a deal is underwritten and approved, the GP has to turn it into a capital raise: an LP-facing deal summary, return projections, the investment thesis, and the subscription materials that go into the investor portal. A capital-raise copilot takes the underwritten deal data — the same numbers and property facts already sitting in the deal-side system — and drafts the investor memo, the projected-return narrative, and the personalized LP outreach, in a format the GP reviews and sends. The deal stops being re-built from scratch for the raise; it carries across.

LP reporting that writes its own first draft

After the raise, the recurring burden is reporting. Quarterly LP updates, distribution notices, and fund-level commentary are still written by hand at most firms even when the underlying data already lives in Juniper Square. An LP reporting agent drafts these from the underlying numbers — variance tables, portfolio roll-ups, narrative context — as a first draft the GP reviews, not one they rewrite. The principle throughout: AI doesn't replace Dealpath or Juniper Square. It feeds both and connects the deal side to the capital side so the same facts don't get keyed three times.

Lifecycle Fit: Where Each Platform Lives

Mapped onto the CRE lifecycle, the division of labor is clean — and it shows you exactly where the automation layer connects the two:

Sourcing: Deals surface from brokers, marketplaces, and signals. AI intake captures them into Dealpath automatically.
Underwriting: Models get built and screened. An AI copilot pre-fills them and writes results back onto the Dealpath record — see best CRE deal-management software for the pipeline category.
IC & Diligence: Checklists, document rooms, and ARGUS/DocuSign workflows run in Dealpath through to approval.
Capital Raise: The approved deal becomes an offering. A capital-raise copilot turns the deal data into LP materials and pushes the offering into Juniper Square.
Subscriptions & Distributions: Online subscriptions, capital calls, and waterfall distributions run in Juniper Square.
LP / IR Reporting: Capital-account statements, quarterly updates, and K-1 packages live in Juniper Square, with the LP-reporting agent drafting the narrative.

Dealpath owns the left half of that timeline; Juniper Square owns the right half; automation owns the seam at the capital raise where the deal becomes the offering.

The Bottom Line

If your firm's constraint is finding, screening, and closing deals, anchor on Dealpath. If your constraint is raising capital and keeping LPs reported and serviced, anchor on Juniper Square. Most firms that grow eventually run both — Dealpath on the deal side, Juniper Square on the capital side — and that's the institutional norm, not a failure of consolidation. Pick based on which pain is bleeding fastest today, and add the second when the other side starts to break.

Whichever you start with, the leverage is in not re-building the same deal data by hand as it moves from acquisition to capital raise to LP reporting. The fastest payback is automating deal intake on one end and the deal-to-capital-raise bridge on the other. If you want to map which automations give your firm the fastest payback on your current stack, our free roadmap call is the place to start.

For the full picture of how these tools fit together, see the complete CRE software stack, our best CRE deal-management software guide, and our best investor-portal software for real estate funds roundup.